Prevalence of Cow's Milk Allergy in Infants from an Urban, Low-Income Population in Chile: A Cohort Study

Sylvia Cruchet1, María Eugenia Arancibia2, Andrés Maturana2

  • 1Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago 7830490, Chile.

Nutrients
|June 13, 2025
PubMed

Insights

Cow's milk allergy (CMA) affects 4.9% of infants in a Chilean cohort, predominantly non-IgE mediated. Early diagnosis and oral food challenges are crucial for managing this common infant allergy.

Area of Science:

  • Pediatrics
  • Allergology
  • Immunology

Background:

  • Cow's milk allergy (CMA) is a prevalent food allergy in infants, with varying prevalence and immune mechanisms globally.
  • Limited data exists on CMA in low- and middle-income regions, necessitating further research.

Purpose of the Study:

  • To determine the prevalence and clinical characteristics of CMA in infants from an urban, low-income Chilean population.
  • To investigate the predominant immune mechanisms (IgE vs. non-IgE mediated) in this population.

Main Methods:

  • Prospective cohort study of 552 healthy newborns followed for 12 months.
  • Screening for symptoms, clinical evaluation, exclusion diet, and open oral food challenge (OFC) for diagnosis.
  • Data collection included sociodemographics, perinatal factors, and parental atopy.

Main Results:

  • CMA prevalence was 4.9% (95% CI 3.1-7.0%), with all cases being non-IgE mediated (vomiting, dermatitis, colic).
  • Diagnosis occurred before 6 months in 74% of cases; 40% developed oral tolerance by 12 months.
  • Parental atopic traits were more frequent in CMA cases, though other characteristics were similar.

Conclusions:

  • CMA prevalence in this Chilean cohort is comparable to high-income countries, with a predominance of non-IgE mediated forms.
  • Findings highlight the need for standardized diagnostic protocols, including OFC, in diverse populations.
  • Further research on long-term outcomes and risk factors for non-IgE mediated CMA is warranted.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
296
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
824